TOLFEDINE 60 MG TABLETS
Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
Charakterystyka produktu
(SPC)
29-08-2015
Niektóre dokumenty dotyczące tego produktu nie są obecnie dostępne, możesz wysłać zapytanie do naszej obsługi klienta, a my powiadomimy Cię, gdy tylko będziemy w stanie je uzyskać.
Wysłać prośbę.
Wysłać prośbę.
Składnik aktywny:
TOLFENAMIC ACID
Dostępny od:
Vetoquinol Ireland Limited
Kod ATC:
QM01AG02
INN (International Nazwa):
TOLFENAMIC ACID
Dawkowanie:
60 mg/tablet
Forma farmaceutyczna:
Tablets
Typ recepty:
POM
Grupa terapeutyczna:
Canine
Dziedzina terapeutyczna:
Tolfenamic acid
Wskazania:
N.S.A.I.D
Status autoryzacji:
Authorised
Data autoryzacji:
1993-08-12
Charakterystyka produktu
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tolfedine 60 mg tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE
Tolfenamic Acid
60mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Tablet
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of acute inflammation due to chronic locomotor disease.
4.3 CONTRAINDICATIONS
Concurrent administration with other steroidal or non-steroidal anti-inflammatory drugs.
Do not use in animals with suspected gastro-duodenal ulceration.
Do not use in animals with impaired renal or hepatic function.
Do not use in pregnant animals.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 14/08/2015_
_CRN 7021600_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
Do not exceed the stated dose or duration of treatment.
Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided,
careful clinical management is essential. Reduced metabolism and excretion in these animals should be considered.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal as there is a potential risk of increased renal toxicity.
It is preferable that TOLFEDINE is not administered to animals undergoing general anaesthesia until fully recovered.
Where there is appearance of bloody or black faeces, a veterinary surgeon should be contacted for advice and the
possibility of stopping treatment should be considered.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDI
Przeczytaj cały dokument
